home *** CD-ROM | disk | FTP | other *** search
- BUSINESS, Page 54Business NotesPHARMACEUTICALSPrescription For a Merger
-
-
- Tums, meet Tagamet. The race to create global pharmaceutical
- companies inspired a transatlantic merger last week. London's
- Beecham Group, maker of Tums antacid, and Philadelphia's
- SmithKline Beckman, developer of the anti-ulcer drug Tagamet,
- said they will form a company with more than $6.7 billion in
- total sales. The merged corporation, to be renamed SmithKline
- Beecham, will rank No. 2 in the pharmaceutical world to New
- Jersey-based Merck.
-
- The move comes none too soon for SmithKline, which has
- suffered from declining Tagamet sales as the once revolutionary
- drug faces increased competition. Industry experts see the two
- companies as a good match. Beecham, which also makes Brylcreem,
- has built strong European markets, while SmithKline prevails in
- North America and Japan.
-
-
-